By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novartis AG 

Lichtstrasse 35

Basel    CH-4056  Switzerland
Phone: 41-0-61-3241111 Fax: 41-0-61-3248001



Company News
Novartis AG (NVS) Set To Become Biosimilar Pioneer By 2020 7/20/2016 7:50:44 AM
Novartis AG (NVS) in No Hurry to Sell Its 36.5% Stake in Consumer Health JV With GlaxoSmithKline (GSK) 7/20/2016 7:41:55 AM
FDA Spurns Novartis AG (NVS)'s Copy of Amgen (AMGN) Blockbuster Neulasta 7/19/2016 7:14:39 AM
Pfizer (PFE) and Novartis AG (NVS)-Backed Startup Quartet Medicine Names a New CEO 7/19/2016 5:51:21 AM
3 Big Pharmas That Have Plenty of Cash to Pay Out Investors 7/15/2016 6:21:18 AM
FDA Staff Says Novartis AG (NVS) Copy of Amgen (AMGN)'s Blockbuster Enbrel is 'Highly Similar' 7/11/2016 6:49:52 AM
Novartis AG (NVS) Announces FDA Approval Of Xolair (Omalizumab) For Pediatric Allergic Asthma 7/8/2016 6:52:44 AM
Novartis AG (NVS) PKC412 (Midostaurin) Pivotal Data Published In The New England Journal of Medicine Show 60% Response Rate In Advanced Systemic Mastocytosis (SM) 6/30/2016 6:13:02 AM
Novartis AG (NVS) Release: Largest Global Psoriasis Survey Shows 85% Of U.S. Respondents Faced Social Stigma Like Discrimination And Humiliation Because Of Their Skin 6/29/2016 8:01:07 AM
Novartis AG (NVS) Taps Xencor's Bispecifics Expertise in $150 Million Immuno-Oncology Deal 6/28/2016 6:36:14 AM